High Throughput Process Development Market : Product Launches was the Key Growth Strategy Adopted by Players

on
The high throughput process development market is highly competitive in nature. Some of the major players in this market include are Danaher Corporation (U.S.), GE Healthcare (U.S.), Agilent Technologies (U.S.), Merck Millipore (Germany), and Thermo Fisher Scientific (U.S.). The strong position of these companies in the market can primarily be attributed to their global presence and broad product portfolio. Other major players in the market include Tecan (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), and Sartorius Stedim Biotech Group (France).

Danaher Corporation is a global science and technology driven company that designs, manufactures, and markets medical, industrial, and commercial products and services. The company strategically concentrates on developing new and innovative products to strengthen its position in the global high throughput process development market. For instance, in April 2015, Molecular Devices, LLC (a subsidiary of Danaher Corporation) launched the SpectraMax i3x Multi-Mode Microplate Reader for in-depth cellular pathway analysis. For this purpose, the company significantly invests in R&D activities. In 2015, it invested 6.75% of its revenue in R&D activities. The company witnessed a 0.5% increase in its revenue from 2014 to 2015. The revenue growth is primarily attributed to the increase in the price of products offered in the process solutions business. It also focused on acquisitions to fortify its position in the market. In April 2014, Beckman Coulter, Inc., along with Cytojene Corporation (U.S.), acquired Xitogen Technologies Inc. (China), a flow cytometer developer. This acquisition helped the company to expand its business in the Asia-Pacific market.

GE Healthcare (U.S.) is another major player in the high throughput process development market. To strengthen its position in the market, the company strategically invests in product launches. For example, in April 2016, GE Healthcare launched UNICORN 7, a system control software used in research, process development, and manufacturing. Through this launch, the company expanded its product offering in the UNICORN software segment. In addition, GE Healthcare has also adopted inorganic strategies such as agreements. For example, GE Healthcare Life Sciences entered into an agreement with Zenith Technologies (Ireland), a company which delivers manufacturing execution systems (MES), automation, and process control excellence to life science companies across the globe. The agreement enabled GE Healthcare to integrate Zenith’s process control systems, MES, and other supporting technologies with its start-to-finish technologies and solutions to support biopharmaceutical manufacturing


The company strives to launch new products in order to strengthen its business position in the market. Besides the product launches, the company also focuses on other strategies such as expansions. In accordance with this, in January 2017, the company established its process development centers in Boston (U.S.) and Shanghai (China). These centers will provide a full range of process development services, which include cell line development services, both upstream and downstream process development, as well as non-GMP clinical production

Agilent Technologies, Inc. (U.S.) is one of the leading players in the HTPD market. It has been adopting organic as well as inorganic growth strategies to ensure its key position in the global market. The company is focusing on developing and introducing new technologies to the market. Agilent Technologies, Inc. launched a number of products to enhance their market share, namely, 1260 Infinity II LC system, a new core platform of the InfinityLab LC Series; 4200 TapeStation System, a fully automated system for higher throughput and quality screening; and upgraded its existing SurePrint gene expression assay.





Comments

Post a Comment